Leukotriene Receptor Antagonist Therapy

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 2000 Nov 21

PMID 11085767

Citations 11

Authors

O J Dempsey

Affiliations

Soon will be listed here.

Abstract

Leukotriene receptor antagonists (LTRA) are a new class of drugs for asthma treatment, available in tablet form. Their unique mechanism of action results in a combination of both bronchodilator and anti-inflammatory effects. While their optimal place in asthma management is still under review, LTRA represent an important advance in asthma pharmacotherapy.

Citing Articles

Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.

Manuel A, Gottlieb A, Freeman L, Zhao Z Mult Scler. 2024; 30(6):696-706.

PMID: 38660773 PMC: 11073911. DOI: 10.1177/13524585241240398.

Gastroprotective effect of zafirlukast against indomethacin induced gastric ulcer in rats via PGE2 and anti-inflammatory pathways.

Aal-Aaboda M, Al-Juhaishi A, Khalil A, Abdulkareem N Iran J Basic Med Sci. 2023; 26(7):799-804.

PMID: 37396939 PMC: 10311973. DOI: 10.22038/IJBMS.2023.71491.15540.

Hematopoietic 12/15-lipoxygenase activity negatively contributes to fungal-associated allergic asthma.

Makullah M, Ellis D, Jones M, Steele C Am J Physiol Lung Cell Mol Physiol. 2023; 325(2):L104-L113.

PMID: 37253655 PMC: 10393346. DOI: 10.1152/ajplung.00090.2023.

Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms.

Fiala S, Fleit H Clin Exp Immunol. 2023; 212(1):14-28.

PMID: 36879430 PMC: 10081111. DOI: 10.1093/cei/uxad031.

ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.

Karimi L, Vijverberg S, Engelkes M, Hernandez-Pacheco N, Farzan N, Soares P Clin Exp Allergy. 2021; 51(9):1157-1171.

PMID: 34128573 PMC: 8503671. DOI: 10.1111/cea.13965.

References

Sarau H, Ames R, Chambers J, Ellis C, Elshourbagy N, FOLEY J . Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol. 1999; 56(3):657-63. DOI: 10.1124/mol.56.3.657. View

Kemp J, Minkwitz M, Bonuccelli C, Warren M . Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Chest. 1999; 115(2):336-42. DOI: 10.1378/chest.115.2.336. View

Bronsky E, Kemp J, Zhang J, Guerreiro D, Reiss T . Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther. 1997; 62(5):556-61. DOI: 10.1016/S0009-9236(97)90051-5. View

Nathan R, Bernstein J, Bielory L, Bonuccelli C, Calhoun W, Galant S . Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol. 1998; 102(6 Pt 1):935-42. DOI: 10.1016/s0091-6749(98)70331-8. View

In K, Asano K, Beier D, Grobholz J, Finn P, Silverman E . Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest. 1997; 99(5):1130-7. PMC: 507922. DOI: 10.1172/JCI119241. View

Kemp J, Dockhorn R, Shapiro G, Nguyen H, Reiss T, Seidenberg B . Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr. 1998; 133(3):424-8. DOI: 10.1016/s0022-3476(98)70281-1. View

Dworski R, FitzGerald G, OATES J, Sheller J . Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994; 149(4 Pt 1):953-9. DOI: 10.1164/ajrccm.149.4.8143061. View

Knorr B, Matz J, Bernstein J, Nguyen H, Seidenberg B, Reiss T . Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA. 1998; 279(15):1181-6. DOI: 10.1001/jama.279.15.1181. View

Nakasato H, Ohrui T, Sekizawa K, Matsui T, Yamaya M, Tamura G . Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J Allergy Clin Immunol. 1999; 104(3 Pt 1):585-8. DOI: 10.1016/s0091-6749(99)70327-1. View

10.

Busse . Leukotrienes and inflammation . Am J Respir Crit Care Med. 1998; 157(6 Pt 1):S210-3. View

11.

Drazen J, Yandava C, Dube L, Szczerback N, Hippensteel R, Pillari A . Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. 1999; 22(2):168-70. DOI: 10.1038/9680. View

12.

Drazen J, Israel E, OByrne P . Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999; 340(3):197-206. DOI: 10.1056/NEJM199901213400306. View

13.

Finnerty J, Wood-Baker R, THOMSON H, Holgate S . Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis. 1992; 145(4 Pt 1):746-9. DOI: 10.1164/ajrccm/145.4_Pt_1.746. View

14.

BROCKLEHURST W . The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960; 151:416-35. PMC: 1363273. DOI: 10.1113/jphysiol.1960.sp006449. View

15.

DCruz D, Barnes N, Lockwood C . Difficult asthma or Churg-Strauss syndrome?. BMJ. 1999; 318(7182):475-6. PMC: 1114944. DOI: 10.1136/bmj.318.7182.475. View

16.

Tashkin D, Nathan R, Howland W, Minkwitz M, Simonson S, Bonuccelli C . An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses. J Allergy Clin Immunol. 1999; 103(2 Pt 1):246-54. DOI: 10.1016/s0091-6749(99)70498-7. View

17.

Cowburn A, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A . Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998; 101(4):834-46. PMC: 508632. DOI: 10.1172/JCI620. View

18.

Menendez R, Venzor J, Ortiz G . Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann Allergy Asthma Immunol. 1998; 80(3):225-6. DOI: 10.1016/S1081-1206(10)62961-4. View

19.

Schotland H . New treatments for exercise-induced asthma. N Engl J Med. 1998; 339(3):192-3. DOI: 10.1056/NEJM199807163390309. View

20.

Lipworth B . Leukotriene-receptor antagonists. Lancet. 1999; 353(9146):57-62. DOI: 10.1016/S0140-6736(98)09019-9. View